Advertisement
Journal Home
Search for

Volume 111, Issue 10, Pages 829-834 (December 2009)


View previous. 9 of 31 View next.

Evaluation of regional cerebral blood flow in cerebellar variant of multiple system atrophy using FineSRT

Noriyuki KimuraCorresponding Author Informationemail address, Toshihide Kumamoto, Teruaki Masuda, Yuki Nomura, Takuya Hanaoka, Yusuke Hazama, Toshio Okazaki

Received 10 March 2009; received in revised form 12 July 2009; accepted 13 August 2009.

Abstract 

Objectives

In the present study, we compared the patterns of regional cerebral blood flow (rCBF) between cerebellar variant of multiple system atrophy (MSA-C) and the late-onset cortical cerebellar ataxia (LCCA) using FineSRT.

Patients and methods

We performed 99mTc ethylcysteinate dimer (ECD) single-photon emission computed tomography in 11 patients with MSA-C (mean age 65.7 years), 7 patients with LCCA (mean age 62.0 years), and 12 age-matched healthy controls (mean age 64.1 years). The rCBF in the region of interest (ROI) was measured by the noninvasive Patlak plot method and calculated using FineSRT, which is a fully automated the ROI technique.

Results

All patients with MSA-C had various degrees of atrophy in the brainstem and middle cerebellar peduncles and 4 of 11 patients showed a clear ‘hot cross bun’ sign in pontine base on T2-weighted MR images. All patients with LCCA showed the various degrees of atrophy in cerebellum without brainstem. FineSRT revealed the significantly decreased rCBF in the caudate tail, fusiform, lingual, cerebellum, midbrain, and pons in MSA-C group compared with controls. Moreover, MSA-C group showed significantly decreased rCBF in the pons compared with LCCA group.

Conclusion

We suggest that a widespread brain involvement is present in patients with MSA-C and the decreased rCBF in the pons may support the differential diagnosis between MSA-C and LCCA.

Department of Internal Medicine III, Oita University, Faculty of Medicine, Idaigaoka 1-1, Hasama, Yufu, Oita 879-5593, Japan

Corresponding Author InformationCorresponding author. Tel.: +81 97 586 5814; fax: +81 97 586 6502.

PII: S0303-8467(09)00229-7

doi:10.1016/j.clineuro.2009.08.014


View previous. 9 of 31 View next.

Advertisement